Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACT and esketamine in treatment-resistant anxiety
RBR-33n8fc7Phase 1Recruiting
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of esketamine, sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Started May 2026; status: recruiting.
02
Drugs
esketamine
Beyond the preview
Go deeper on RBR-33n8fc7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-33n8fc7.